DiaCarta named one of MedTech Outlook’s Top 10 In Vitro Diagnostic Technology Solutions Providers 2018
FREMONT, Calif .– (COMMERCIAL THREAD) – DiaCarta has been recognized as one of the top 10 providers of in vitro diagnostic technology solutions 2018 by Med Tech Outlook Magazine. The positioning is based on an assessment of DiaCarta’s specialty in genomic testing for biomarkers, personalized diagnostics and clinical sample testing service provided in their CLIA certified laboratory. The award list is selected by a panel of experts and MedTech Outlook editorial board members to recognize and promote cutting-edge in vitro diagnostic technology that is creating immense impact in the US market and dedicates its determination to create a big difference in this constantly evolving field. .
“We are proud to honor DiaCarta as one of the top 10 companies specializing in providing in vitro diagnostic solutions. We value DiaCarta’s XNA technology which enables ultra-sensitive detection of exploitable mutations using qPCR, Next Generation Sequencing (NGS) and other platforms for liquid biopsy, FFPE and other traditionally difficult samples, ”said Alex D’souza, editor-in-chief of MedTech Outlook.
“We are honored to be selected by MedTech Outlook,” said Aiguo (Adam) Zhang, CEO and Founder of DiaCarta, “This helps validate and further reaffirm our strategic and technical goals of delivering highly sensitive and advanced technologies for redefining how and translational genomics impacts healthcare treatment plans.
DiaCarta is a Richmond, California-based translational genomics and personalized diagnostics company with significant business operations in China. DiaCarta provides highly sensitive and advanced technologies that will improve the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals worldwide. With over 20,000 square feet dedicated to GMP compliant laboratory space as well as CLIA and ISO 13485 certifications, DiaCarta is changing the landscape of molecular diagnostics.
About MedTech Outlook
Published from Fremont, California, MedTech Outlook is a print magazine that covers the most important and recent developments in the healthcare industry. Medical Tech Outlook magazine is a bright, interactive and powerful platform that incubates the facts and ideas of the medical device industry. All the latest updates, market information, and industry technological developments are presented to our group of elite and well-to-do readers to understand the essential developments towards the use of wearable technology as it continues to gain traction. place in traditional health care.